Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2023 May 22:14:1188330.
doi: 10.3389/fimmu.2023.1188330. eCollection 2023.

Cardiovascular involvement in Epstein-Barr virus infection

Affiliations
Review

Cardiovascular involvement in Epstein-Barr virus infection

Xinying Chen et al. Front Immunol. .

Abstract

Cardiovascular involvement is an uncommon but severe complication of Epstein-Barr virus (EBV) infection caused by direct damage and immune injury. Recently, it has drawn increasing attention due to its dismal prognosis. It can manifest in various ways, including coronary artery dilation (CAD), coronary artery aneurysm (CAA), myocarditis, arrhythmias, and heart failure, among others. If not treated promptly, cardiovascular damage can progress over time and even lead to death, which poses a challenge to clinicians. Early diagnosis and treatment can improve the prognosis and reduce mortality. However, there is a lack of reliable large-scale data and evidence-based guidance for the management of cardiovascular damage. Consequently, in this review, we attempt to synthesize the present knowledge of cardiovascular damage associated with EBV and to provide an overview of the pathogenesis, classification, treatment, and prognosis, which may enhance the recognition of cardiovascular complications related to EBV and may be valuable to their clinical management.

Keywords: Epstein–Barr virus (EBV); cardiovascular damage; coronary artery lesions (CALs); immune injury; myocarditis.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Figures

Figure 1
Figure 1
Pathogenesis of cardiovascular damage. The mechanism of cardiovascular damage caused by Epstein–Barr virus (EBV) infection is mainly divided into direct and indirect damage. Direct damage refers to the positive detection rate of the EBV virus gene in endomyocardial samples. Indirect damage, also called immune damage, consists of innate and adaptive immune activations that cause cardiac involvements, such as coronary artery lesions, myocarditis, pericardial diseases, valvular heart disease, and heart failure. This figure was drawn on the Figdraw website (https://www.figdraw.com/static/index.html).
Figure 2
Figure 2
Differences in cardiovascular manifestations in Epstein–Barr virus (EBV) infection between children and adults. The spectrum of cardiovascular manifestations associated with EBV differs between children and adults: coronary artery lesions, valvulopathy, and pericardial effusion are more common in children, while myocarditis and heart failure usually occur in adults. This figure was drawn with the Canva software and the health icons accessed at https://healthicons.org/.

Similar articles

Cited by

References

    1. Cohen JI. Epstein-Barr virus infection. N Engl J Med (2000) 343:481–92. doi: 10.1056/NEJM200008173430707 - DOI - PubMed
    1. Wakiguchi H. Overview of epstein-barr virus-associated diseases in japan. Crit Rev Oncol Hematol (2002) 44:193–202. doi: 10.1016/s1040-8428(02)00111-7 - DOI - PubMed
    1. Nowalk A, Green M. Epstein-Barr virus. Microbiol Spectr. (2016) 4(3):4–3. doi: 10.1128/microbiolspec.DMIH2-0011-2015 - DOI - PubMed
    1. Damania B, SC K, Raab-Traub N. Epstein-Barr virus: biology and clinical disease. Cell (2022) 185:3652–70. doi: 10.1016/j.cell.2022.08.026 - DOI - PMC - PubMed
    1. Kimura H, Morishima T, Kanegane H, Ohga S, Hoshino Y, Maeda A, et al. . Prognostic factors for chronic active epstein-barr virus infection. J Infect Dis (2003) 187:527–33. doi: 10.1086/367988 - DOI - PubMed

Publication types